RAYTHEON CO's ticker is RTN and the CUSIP is 755111507. A total of 820 filers reported holding RAYTHEON CO in Q1 2015. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
About RAYTHEON CO
Raytheon Co. is a leading technology and innovation company that specializes in defense, civil government, and cybersecurity solutions. With a history spanning over 90 years, Raytheon has established itself as a trusted partner to governments and businesses around the world.
One of the key strengths of Raytheon is its focus on research and development. The company invests heavily in cutting-edge technologies and has a strong track record of delivering innovative solutions to its customers. This has helped Raytheon to stay ahead of the competition and maintain its position as a leader in the industry.
Another factor that sets Raytheon apart is its commitment to sustainability. The company has set ambitious goals to reduce its environmental impact and has implemented a number of initiatives to achieve these goals. This includes reducing greenhouse gas emissions, conserving water, and minimizing waste.
Despite the challenges posed by the COVID-19 pandemic, Raytheon has continued to perform well. The company reported strong financial results in the first quarter of 2021, with net sales of $15.2 billion and earnings per share of $0.90. This is a testament to the resilience of the company and its ability to adapt to changing market conditions.
Overall, Raytheon is a company that is well-positioned for long-term success. With its focus on innovation, sustainability, and strong financial performance, Raytheon is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $248,000 | 0.0% | 1,821 | 0.0% | 0.07% | -5.3% |
Q2 2016 | $248,000 | -30.1% | 1,821 | -37.1% | 0.08% | -26.9% |
Q1 2016 | $355,000 | -1.4% | 2,894 | 0.0% | 0.10% | +1.0% |
Q4 2015 | $360,000 | +13.9% | 2,894 | 0.0% | 0.10% | +12.0% |
Q3 2015 | $316,000 | +206.8% | 2,894 | +169.7% | 0.09% | +253.8% |
Q2 2015 | $103,000 | -12.0% | 1,073 | 0.0% | 0.03% | -13.3% |
Q1 2015 | $117,000 | +0.9% | 1,073 | 0.0% | 0.03% | 0.0% |
Q4 2014 | $116,000 | +6.4% | 1,073 | 0.0% | 0.03% | 0.0% |
Q3 2014 | $109,000 | +6.9% | 1,073 | +4.2% | 0.03% | +20.0% |
Q1 2014 | $102,000 | – | 1,030 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brick & Kyle, Associates | 62,251 | $4,480 | 2.38% |
Providence Wealth Advisors, LLC | 6,475 | $462,478 | 0.52% |
PHYSICIANS FINANCIAL SERVICES, INC. | 14,579 | $1,049 | 0.43% |
Shakespeare Wealth Management, LLC | 8,383 | $603,325 | 0.21% |